Evidence map›Paper›PMID 40833000›Full record

ArticleAnnals of African medicine2026

Gliptin-induced Pemphigus.

Avinash Jadhav, Sandra Arora, Ashwini Dattatray Mundhe

Abstract readCase Reports
In one paragraph

Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Avinash JadhavDepartment of Dermatology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.
Sandra Arora
Ashwini Dattatray Mundhe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractThis case highlights the development of gliptin-induced pemphigus in a patient shortly after initiating gliptin therapy for diabetes. It is essential to differentiate drug-induced pemphigus from idiopathic cases, as they can be clinically and histopathologically indistinguishable. A detailed medical history, including medication use, is crucial to identifying drug-induced conditions. The time interval between initiating the suspected drug and the onset of skin manifestations can vary widely from case to case. Improvement of the lesions following drug cessation confirms the diagnosis of drug-induced pemphigus.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsPemphigusFemaleHumansMaleMiddle AgedTreatment OutcomeHypoglycemic AgentsDiabèteDiabetesgliptingliptinepemphigus

Identifiers

PMID40833000
PMCPMC13249341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.